FRONT CELL INFECT MI 润色咨询

Frontiers in Cellular and Infection Microbiology

出版年份:暂无数据 年文章数:4692 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:8.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-08-25 ms8000000563552859 来自江苏省

    审稿速度:1.0 | 投稿命中率:95.0
    经验分享:wu

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-08-24 ms6000000127821627 来自澳大利亚

    审稿速度:3.0
    偏重的研究方向:肠道菌群
    经验分享:5月20投稿
    8月2日第一个审稿人意见返回
    8月5号第二个审稿人意见返回并finalized
    8月11号交互评审
    8月19号提交回复及修改稿
    8月20 进入review finalized阶段
    8月24 收到接收邮件

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2021-06-24 123971fdm77暂无昵称

    proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。

    13

    展开13条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-05-09 ms7000000507856696 来自江苏省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:肿瘤
    经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-01-27 Asmallriver 来自湖南省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:传染病
    经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2023-02-17 lqby321 来自山东省

    偏重的研究方向:传染病;微生物学
    经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-08-13 ms8000000186303669

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:传染病;微生物;病毒学
    经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-06-05 ms4000001113754282

    提交13天了还没有任命编辑和审稿人,该怎么办

    8

    展开8条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-11-13 Dr.jia

    暂时还没有

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2154494, encodeId=1366215449421, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享:wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd226572749, createdName=ms8000000563552859, createdTime=Fri Aug 25 09:05:10 CST 2023, time=2023-08-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154340, encodeId=ccbb2154340a3, content=审稿速度:3.0<br>偏重的研究方向:肠道菌群<br>经验分享:5月20投稿<br>8月2日第一个审稿人意见返回<br>8月5号第二个审稿人意见返回并finalized<br>8月11号交互评审<br>8月19号提交回复及修改稿<br>8月20 进入review finalized阶段<br>8月24 收到接收邮件<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88258387646, createdName=ms6000000127821627, createdTime=Thu Aug 24 08:57:42 CST 2023, time=2023-08-24, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=976645, encodeId=e8ee9e66456b, content=proof后2个多月都还没在线发表,比我后接收一个月的都在线了,关键是这还是是OA期刊,搞不懂。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=671, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8542420944, createdName=123971fdm77暂无昵称, createdTime=Thu Jun 24 23:13:47 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131251, encodeId=e0b021312512a, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:本人作为客座编辑在frontiers cellular infection microbiology(IF6.073)期刊开了一个主题为“New Insights into the Role of Tumor Microbial Microenvironment in Tumor Immunotherapy”的专刊,现在已经开放投稿。如果大家有主题相关的稿件,欢迎大家积极投稿。投稿完成后,我会第一时间处理稿件并择优选择你们投稿时推荐的审稿专家,提升稿件处理流程和接收速度。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Tue May 09 22:50:16 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2111587, encodeId=4cf0211158ecb, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病<br>经验分享:中过一次了,感觉比较容易中,这几天又投了一个,凌晨12点投的,早上5点起床看已经分配编辑了。不知道结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqz1JJib9x1sPvL72jJHNRTac4co6mxuJib3hahuxVLVVRXks28xP5d5Hibl7cBuuYkfU6S16HK4dEtA/132, createdBy=7add2279854, createdName=Asmallriver, createdTime=Fri Jan 27 09:03:54 CST 2023, time=2023-01-27, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2115177, encodeId=041b21151e790, content=偏重的研究方向:传染病;微生物学<br>经验分享:杂志编辑非常负责,审稿人意见很中肯,个人觉得该杂志文章质量不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/gCTJBEQ5byrcLVTrgfDXfla5W6WWlUKBXwXrNf9ibibsIW1nPGLgd2rMDBcSbSyznMzBuRwEPMbyhx1iazzMKXAxw/132, createdBy=653e2361163, createdName=lqby321, createdTime=Fri Feb 17 23:55:26 CST 2023, time=2023-02-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1238549, encodeId=8f2d1238549e6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:传染病;微生物;病毒学<br>经验分享:6.28投 6.30分配编辑 7.2送外审 7.12reviewer1意见 7.14reviewer2意见 7.22reviewer3意见 7.26上传修改稿(只给了4天) 没有互动评论环节 8.2接收 8.18见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92988208131, createdName=ms8000000186303669, createdTime=Sat Aug 13 23:04:57 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224649, encodeId=026f12246490c, content=提交13天了还没有任命编辑和审稿人,该怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=197d5555876, createdName=ms4000001113754282, createdTime=Sun Jun 05 23:36:17 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100348, encodeId=cec72100348df, content=暂时还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201230/d0d1d2e52ea0422bba7efe71ce855b25/fa6df5821f504eb2a0f1031ff46d671e.jpg, createdBy=ea845448906, createdName=Dr.jia, createdTime=Sun Nov 13 23:20:57 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0<br>偏重的研究方向:肠道微生物<br>经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=)]
    2022-06-14 ms5000001536683150

    投稿命中率:25.0
    偏重的研究方向:肠道微生物
    经验分享:转投过来的,一直是Initial Validation,快一周多了,还没有分配编辑

    2

    展开2条回复
共122条页码: 1/13页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分